177 related articles for article (PubMed ID: 25451105)
21. Heat exposure enhances radiosensitivity by depressing DNA-PK kinase activity during double strand break repair.
Ihara M; Takeshita S; Okaichi K; Okumura Y; Ohnishi T
Int J Hyperthermia; 2014 Mar; 30(2):102-9. PubMed ID: 24571173
[TBL] [Abstract][Full Text] [Related]
22. Understanding DNA damage response and DNA repair pathways: applications to more targeted cancer therapeutics.
Kinsella TJ
Semin Oncol; 2009 Apr; 36(2 Suppl 1):S42-51. PubMed ID: 19393835
[TBL] [Abstract][Full Text] [Related]
23. The BRCA2 gene is a potential molecular target during 5-fluorouracil therapy in human oral cancer cells.
Nakagawa Y; Kajihara A; Takahashi A; Kondo N; Mori E; Kirita T; Ohnishi T
Oncol Rep; 2014 May; 31(5):2001-6. PubMed ID: 24627042
[TBL] [Abstract][Full Text] [Related]
24. Targeting homologous recombination repair defects in cancer.
Evers B; Helleday T; Jonkers J
Trends Pharmacol Sci; 2010 Aug; 31(8):372-80. PubMed ID: 20598756
[TBL] [Abstract][Full Text] [Related]
25. Akt promotes post-irradiation survival of human tumor cells through initiation, progression, and termination of DNA-PKcs-dependent DNA double-strand break repair.
Toulany M; Lee KJ; Fattah KR; Lin YF; Fehrenbacher B; Schaller M; Chen BP; Chen DJ; Rodemann HP
Mol Cancer Res; 2012 Jul; 10(7):945-57. PubMed ID: 22596249
[TBL] [Abstract][Full Text] [Related]
26. Molecular inhibitors of DNA repair: searching for the ultimate tumor killing weapon.
Nikitaki Z; Michalopoulos I; Georgakilas AG
Future Med Chem; 2015 Aug; 7(12):1543-58. PubMed ID: 26306465
[TBL] [Abstract][Full Text] [Related]
27. Targeting homologous recombination-mediated DNA repair in cancer.
Carvalho JF; Kanaar R
Expert Opin Ther Targets; 2014 Apr; 18(4):427-58. PubMed ID: 24491188
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic targeting of a robust non-oncogene addiction to PRKDC in ATM-defective tumors.
Riabinska A; Daheim M; Herter-Sprie GS; Winkler J; Fritz C; Hallek M; Thomas RK; Kreuzer KA; Frenzel LP; Monfared P; Martins-Boucas J; Chen S; Reinhardt HC
Sci Transl Med; 2013 Jun; 5(189):189ra78. PubMed ID: 23761041
[TBL] [Abstract][Full Text] [Related]
29. DNA damaging agents and DNA repair: From carcinogenesis to cancer therapy.
de Almeida LC; Calil FA; Machado-Neto JA; Costa-Lotufo LV
Cancer Genet; 2021 Apr; 252-253():6-24. PubMed ID: 33340831
[TBL] [Abstract][Full Text] [Related]
30. Oxidatively induced DNA damage and its repair in cancer.
Dizdaroglu M
Mutat Res Rev Mutat Res; 2015; 763():212-45. PubMed ID: 25795122
[TBL] [Abstract][Full Text] [Related]
31. Targeting abnormal DNA double strand break repair in cancer.
Rassool FV; Tomkinson AE
Cell Mol Life Sci; 2010 Nov; 67(21):3699-710. PubMed ID: 20697770
[TBL] [Abstract][Full Text] [Related]
32. DNA damage repair and response proteins as targets for cancer therapy.
Lieberman HB
Curr Med Chem; 2008; 15(4):360-7. PubMed ID: 18288990
[TBL] [Abstract][Full Text] [Related]
33. Targeting the DNA Damage Response in Cancer.
O'Connor MJ
Mol Cell; 2015 Nov; 60(4):547-60. PubMed ID: 26590714
[TBL] [Abstract][Full Text] [Related]
34. Cancer TARGETases: DSB repair as a pharmacological target.
Samadder P; Aithal R; Belan O; Krejci L
Pharmacol Ther; 2016 May; 161():111-131. PubMed ID: 26899499
[TBL] [Abstract][Full Text] [Related]
35. Preventing Damage Limitation: Targeting DNA-PKcs and DNA Double-Strand Break Repair Pathways for Ovarian Cancer Therapy.
Dungl DA; Maginn EN; Stronach EA
Front Oncol; 2015; 5():240. PubMed ID: 26579492
[TBL] [Abstract][Full Text] [Related]
36. Histone deacetylase inhibitors as radiosensitisers: effects on DNA damage signalling and repair.
Groselj B; Sharma NL; Hamdy FC; Kerr M; Kiltie AE
Br J Cancer; 2013 Mar; 108(4):748-54. PubMed ID: 23361058
[TBL] [Abstract][Full Text] [Related]
37. Nanotechnology in cancer therapy: targeting the inhibition of key DNA repair pathways.
Aziz K; Nowsheen S; Georgakilas AG
Curr Mol Med; 2010 Oct; 10(7):626-39. PubMed ID: 20712589
[TBL] [Abstract][Full Text] [Related]
38. DNA double-strand break repair in cancer: A path to achieving precision medicine.
Gillyard T; Davis J
Int Rev Cell Mol Biol; 2021; 364():111-137. PubMed ID: 34507781
[TBL] [Abstract][Full Text] [Related]
39. DNA repair targeted therapy: The past or future of cancer treatment?
Gavande NS; VanderVere-Carozza PS; Hinshaw HD; Jalal SI; Sears CR; Pawelczak KS; Turchi JJ
Pharmacol Ther; 2016 Apr; 160():65-83. PubMed ID: 26896565
[TBL] [Abstract][Full Text] [Related]
40. Targeting BER enzymes in cancer therapy.
Visnes T; Grube M; Hanna BMF; Benitez-Buelga C; Cázares-Körner A; Helleday T
DNA Repair (Amst); 2018 Nov; 71():118-126. PubMed ID: 30228084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
